An essential receptor for adeno-associated virus infection
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors are currently the leading candidates for virus-based gene therapies because of their broad tissue tropism, non-pathogenic nature and low immunogenicity. They have been successfully used in clinical trials to treat hereditary diseases such as haemophilia B (ref. 2), and have been approved for treatment of lipoprotein lipase deficiency in Europe. Considerable efforts have been made to engineer AAV variants with novel and biomedically valuable cell tropisms to allow efficacious systemic administration, yet basic aspects of AAV cellular entry are still poorly understood. In particular, the protein receptor(s) required for AAV entry after cell attachment remains unknown. Here we use an unbiased genetic screen to identify proteins essential for AAV serotype 2 (AAV2) infection in a haploid human cell line. The most significantly enriched gene of the screen encodes a previously uncharacterized type I transmembrane protein, KIAA0319L (denoted hereafter as AAV receptor (AAVR)). We characterize AAVR as a protein capable of rapid endocytosis from the plasma membrane and trafficking to the trans-Golgi network. We show that AAVR directly binds to AAV2 particles, and that anti-AAVR antibodies efficiently block AAV2 infection. Moreover, genetic ablation of AAVR renders a wide range of mammalian cell types highly resistant to AAV2 infection. Notably, AAVR serves as a critical host factor for all tested AAV serotypes. The importance of AAVR for in vivo gene delivery is further highlighted by the robust resistance of Aavr(-/-) (also known as Au040320(-/-) and Kiaa0319l(-/-)) mice to AAV infection. Collectively, our data indicate that AAVR is a universal receptor involved in AAV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The peptide insertion at position R588 in R100 sterically prohibits the close proximity between R585 and R588 required for heparan sulfate binding ( Fig. 5 B), suggesting a plausible mechanism for enhanced transit through the heparan sulfate-rich ILM barrier.”
From Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies (2024) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Maxfield, F. R., & McGraw, T. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1315 · Cited by 1,729
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Self-citationMannose 6-phosphate receptors: new twists in the tale
Ghosh, P., Dahms, N. M., & Kornfeld, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1050 · Cited by 1,086
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Campeau, E., Ruhl, V. E., Rodier, F., Smith, C. L., Rahmberg, B. L., Fuss, J. O., Campisi, J., Yaswen, P., Cooper, P. K., & Kaufman, P. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006529 · Cited by 964
Cited by
Items 201–300 of 524
Calton, M. A., Croze, R. H., Burns, C., Beliakoff, G., Vazin, T., Szymanski, P., Schmitt, C., Klein, A., Leong, M., Quezada, M., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.14.1 · Cited by 21
“R100 maintained dependence on the AAV receptor (AAVR) for cell transduction, 46 as demonstrated by a significant decrease in transduction of Hap1 cells lacking AAVR compared to normal Hap1 cells (Fig.”
Engineering novel adeno-associated viruses (AAVs) for improved delivery in the nervous system
Carneiro, A. D., & Schaffer, D. V. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102532 · Cited by 22
An alternate receptor for adeno-associated viruses
Dhungel, B. P., Xu, H., Nagarajah, R., Vitale, J. N., Wong, A. C. H., Gokal, D., Feng, Y., Tabar, M. S., Metierre, C., Parsania, C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.026 · Cited by 24
rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
Blanc, F., Mondain, M., Bemelmans, A., Affortit, C., Puel, J., & Wang, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020589 · Cited by 23
“, being used by a wide variety of different capsid serotypes, was discovered [28], which suggests that other determinants of AAV cellular entry should rather be considered to be co-receptors.”
BackgroundBuscara, L., Gross, D., & Danièle, N. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040258 · Cited by 23
“demonstrated the existence of a co-receptor common to all the tested serotypes (AAV1, 2, 3B, 5, 6, 8 and 9), the previously uncharacterised type I transmembrane protein KIAA0319L, renamed AAVR [78,79].”
BackgroundStrategies for Targeting Neural Circuits: How to Manipulate Neurons Using Virus Vehicles
Hui, Y., Zheng, X., Zhang, H., Li, F., Yu, G., Li, J., Zhang, J., Gong, X., & Guo, G. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.882366 · Cited by 27
“Furthermore, a novel AAV capsid variant, Olig001, permits significant oligodendrocyte preference (> 95%; Powell et al., 2016).”
BackgroundMolecular Engineering of Virus Tropism
He, B., Wilson, B., Chen, S., Sharma, K., Scappini, E., Cook, M., Petrovich, R. M., & Martin, N. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011094 · Cited by 25
“An adeno-associated virus receptor (AAVR) was identified as an universal receptor for multiple AAV serotypes [33].”
BackgroundGuidi, L., Mattley, J., Martínez‐Garay, I., Monaco, A. P., Linden, J. F., Velayos‐Baeza, A., & Molnár, Z. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx269 · Cited by 23
“2009, and unpublished data) which likely mediates endocytosis of KIAA0319L in its role as a receptor for adeno-associated virus (Pillay et al. 2016).”
BackgroundKotterman, M., Beliakoff, G., Croze, R., Vazin, T., Schmitt, C., Szymanski, P., Leong, M., Quezada, M., Holt, J., Barglow, K., et al. (2021) · doi:10.1101/2021.06.24.449775 · Cited by 20
Regenerative medicine improve neurodegenerative diseases
Ashraf, S. S., Sarmadi, V. H., Larijani, G., Gharahgheshlagh, S. N., Ramezani, S., Moghadamifar, S., Mohebbi, S. L., Milan, P. B., Haramshahi, S. M. A., Ahmadirad, N., et al. (2022) · Cell and Tissue Banking · doi:10.1007/s10561-022-10062-0 · Cited by 22
rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
Iglesias, C. F., Ristovski, M., Bolić, M., & Čuperlović‐Culf, M. (2023) · Bioengineering · doi:10.3390/bioengineering10020229 · Cited by 24
FAM91A1–TBC1D23 complex structure reveals human genetic variations susceptible for PCH
Zhao, L., Deng, H., Yang, Q., Tang, Y., Zhao, J., Li, P., Zhang, S., Yong, X., Li, T., Billadeau, D. D., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309910120 · Cited by 21
“KIAA0391L internalization and trafficking assays were performed according to the previous study (41).”
MethodPoller, W. C., Sahoo, S., Hajjar, R. J., Landmesser, U., & Krichevsky, A. M. (2023) · Cells · doi:10.3390/cells12222660 · Cited by 22
“Pillay et al. [304] used an unbiased genetic screen to identify proteins essential for AAV infection and identified a previously uncharacterized type I transmembrane protein, KIAA0319L, which they named AAV receptor (AAVR).”
BackgroundThe application of CRISPR/Cas9–based genome-wide screening to disease research
Chen, X., Zheng, M., Lin, S., Huang, M., Chen, S., & Chen, S. (2024) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2024.102004 · Cited by 25
Advances in viral vector-based delivery systems for gene therapy: a comprehensive review
Singh, K., Jain, D., Sethi, P., Gupta, J. K., Dubey, A., Noman, A. A., lal, S., Sharma, P., & Abdallah, E. M. (2025) · 3 Biotech · doi:10.1007/s13205-025-04366-7 · Cited by 24
“…may typically be compacted to a maximum size of less than 4.7 kb. AAV vectors can transduce specific cells or tissues via the encapsulation of non-genomic DNA that is unrelated to any neurodegenerative or CNS disorder (Pillay et al. 2016; Agbandje-McKenna and Kleinschmidt 2011; Gray et al. 2010).”
InfluentialCabanes‐Creus, M., Navarro, R. G., Liao, S. H. Y., Scott, S., Carlessi, R., Roca-Pinilla, R., Knight, M., Baltazar, G., Zhu, E., Jones, M., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.12.014 · Cited by 20
“However, the same vector packaged with a cassette containing the human cytomegalovirus promoter resulted in a marked pericentral expression profile.14 Given that the capsid was kept constant, our data suggest that, in some instances, promoters can also have a determining role in differential transgene expression acros…”
BackgroundStructural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants
Bennett, A. D., Gargas, J., Kansol, A., Lewis, J., Hsi, J., Hull, J. A., Mietzsch, M., Tartaglia, L. J., Muzyczka, N., Bhattacharya, N., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01772-22 · Cited by 21
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 20
“Once taken up by the host cell, a process that most often appears to rely on endocytosis, a majority of rAAV vectors have been shown to interact with a 150 kDa protein KIAA0319L, now often referred to as the AAV receptor (AAVR) [82].”
BackgroundSchober, A. L., Gagarkin, D. A., Chen, Y., Gao, G., Jacobson, L., & Mongin, A. A. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00262 · Cited by 20
In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia
Dang, C. H., Aubert, M., Feelixge, H. S. D. S., Diem, K., Loprieno, M. A., Roychoudhury, P., Stone, D., & Jerome, K. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-01004-y · Cited by 22
Madigan, V. J., Tyson, T. O., Yuziuk, J. A., Pillai, M., Møller-Tank, S., & Asokan, A. (2019) · Journal of Virology · doi:10.1128/jvi.00943-19 · Cited by 21
“AAV also requires additional attachment factors, including integrins, as well as the recently identified universal AAV receptor (AAVR; KIAA0319L) for cell entry (5).”
BackgroundMethodZhou, G., duan, Y., Ma, G., Wu, W., Hu, Z., Chen, N., Chee, Y. E., Cui, J. Z., Samad, A., Matsubara, J. A., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22045 · Cited by 19
“Adeno-associated viruses (AAVs) are small viruses that are not at present known to cause any disease, and thus their derived vectors have great potential for human gene therapy.(37,38) The eye is an especially ideal target organ for gene therapy, as it is easily accessible and immune privileged.”
BackgroundViral Vectors, Engineered Cells and the CRISPR Revolution
DiCarlo, J. E., Deeconda, A., & Tsang, S. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63904-8_1 · Cited by 21
Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody
Sun, Y., Klose, T., Liu, Y., Modrow, S., & Rossmann, M. G. (2019) · Journal of Virology · doi:10.1128/jvi.01732-18 · Cited by 19
CRISPR Activation Enhances In Vitro Potency of AAV Vectors Driven by Tissue-Specific Promoters
McDougald, D. S., Duong, T. T., Palozola, K. C., Marsh, A., Papp, T. E., Mills, J. A., Zhou, S., & Bennett, J. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.03.004 · Cited by 21
“Recent studies identified and characterized a “universal” transmembrane receptor for AAV infection denoted AAVR.(23,24) We generated”
BackgroundStructural Insight into Non-Enveloped Virus Binding to Glycosaminoglycan Receptors: A Review
Sorin, M. N., Kuhn, J., Stasiak, A. C., & Stehle, T. (2021) · Viruses · doi:10.3390/v13050800 · Cited by 18
“While heparan sulfate was long considered to be the primary receptor for AAVs, recent research suggests that this role is in fact performed by the adeno-associated virus receptor [15], with GAGs serving as lower-affinity co-receptors of significance for attachment.”
BackgroundmRNA therapy for myocardial infarction: A review of targets and delivery vehicles
Wang, X., Wu, D. H., & Senyo, S. E. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1037051 · Cited by 20
“To transfect a cell, AAV first adheres to cytoplasm receptors such as the AAV receptor, and then enters the cell via endocytosis (Pillay et al., 2016).”
MethodMultiparametric domain insertional profiling of adeno-associated virus VP1
Hoffmann, M. D., Zdechlik, A. C., He, Y., Nedrud, D. M., Aslanidi, G., Gordon, W. R., & Schmidt, D. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101143 · Cited by 18
“the recently identified universal AAV receptor (AAVR) to ensure proper trafficking to the trans107 Golgi network (23, 44, 45), undergo the required conformational changes (autoproteolysis, 108 externalization of the N-terminal PLA2 domain (19, 21, 46)) that together mediate virion 109 escape into the cytosol.”
BackgroundNew Directions in Pulmonary Gene Therapy
Vu, A., & McCray, P. B. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.166 · Cited by 21
“The AAV receptor (AAVR), encoded by gene KIAA0319L, is required for infection of AAV serotypes 1, 2, 3b, 5, 6, 8, and 9, and is exclusively localized to the basolateral and perinuclear compartments of HAE cells.(95) AAV2.”
BackgroundAAV-mediated expression of proneural factors stimulates neurogenesis from adult Müller glia in vivo
Pavlou, M., Probst, M., Kaplan, L., Filippova, E., Prieve, A., Rieke, F. M., & Reh, T. A. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00209-3 · Cited by 15
“Both clusters expressed genes AAVR (AU040320), Gpr108 and Tm9sf2 that are essential for AAV transduction (Summerford and Samulski, 2016; Pillay et al, 2016; Meisen et al, 2020) (Fig.”
Roadmap for an early gene therapy for cystic fibrosis airway disease
Carlon, M. S., Vidović, D., & Birket, S. E. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5164 · Cited by 18
“In retrospect, absence of receptors for this serotype at the apical side of the airway epithelium, the weak promoter or effective barriers in CF patients' lungs might have contributed to inefficient gene transfer.(43) Nevertheless, these studies confirmed the favorable safety profile of rAAV with only a few adverse ef…”
BackgroundContext-Specific Function of the Engineered Peptide Domain of PHP.B
Martino, R. A., Fluck, E. C., Murphy, J., Wang, Q., Hoff, H. B., Pumroy, R. A., Lee, C. Y., Sims, J. J., Roy, S., Moiseenkova‐Bell, V. Y., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01164-21 · Cited by 20
Structural Study of Aavrh.10 Receptor and Antibody Interactions
Mietzsch, M., Yu, J. C., Hsi, J., Chipman, P. R., Broecker, F., Fuming, Z., Linhardt, R. J., Seeberger, P. H., Heilbronn, R., McKenna, R., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01249-21 · Cited by 16
“Furthermore, a series of protein receptors have been described, e.g., AAVR (32), avb1 integrin (33), avb5 integrin (34), laminin (35), the hepatocyte growth factor receptor (36), the fibroblast growth factor receptor (37), and platelet-derived growth factor receptor (38).”
InfluentialMacdonald, J., Marx, J., & Büning, H. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.169 · Cited by 18
“53 56 This interaction appears to be required for proper intracellular trafficking of AAV, and it has been observed that AAVR accompanies the particles on their route toward the trans-Golgi network.”
Hu, G., Silveria, M., Zane, G. M., Chapman, M. S., & Stagg, S. M. (2022) · Journal of Virology · doi:10.1128/jvi.00106-22 · Cited by 16
“AAVR was only recently discovered though unbiased genome-wide screening as a receptor key for entry and trafficking (40).”
BackgroundSelf-citationThe human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2
Weber‐Adrian, D., Heinen, S., Silburt, J., Noroozian, Z., & Aubert, I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13898 · Cited by 19
“Glycans possessing terminal N-linked galactose and the laminin receptor (LamR) may act as receptors and coreceptor, respectively, for AAV9 transcytosis (Shen et al. 2011; Nonnenmacher and Weber 2012).”
BackgroundHao, S., Zhang, X., Ning, K., Feng, Z., Park, S. Y., Küz, Ç. A., McFarlin, S., Richart, D., Cheng, F., Zhang, E. Y., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01330-23 · Cited by 17
“Both have been shown to be essential entry factors of transduction in whole-genome gRNA library screens using rAAV2 (12, 21).”
BackgroundMethodInfluentialrAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombination
Ling, C., Yu, C., Wang, C., Yang, M., Yang, H., Yang, K., He, Y., Shen, Y., Tang, S., Yu, X., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae401 · Cited by 15
The Expression and Function of the Small Nonstructural Proteins of Adeno-Associated Viruses (AAVs)
Küz, Ç. A., McFarlin, S., & Qiu, J. (2024) · Viruses · doi:10.3390/v16081215 · Cited by 18
“AAV infection is initiated with its attachment to host cells through glycans and a commonly used proteinaceous receptor known as KIAA0319L (also referred to as AAV receptor, AAVR) [20,21], or alternate receptors [22].”
BackgroundHerrmann, A.-K., Große, S., Börner, K., Krämer, C., Wiedtke, E., Gunkel, M., & Grimm, D. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.085 · Cited by 19
“…Table S2) was cloned into the recently reported AAP expression plasmid, 17 and then the resulting construct was used to trans - complement AAP-deficient helper plasmids (called AAVXmut; with Xdenotingtheserotype) ofserotypes 2, 8, or 9 in small-scale AAV-GFP vector productions (workflow in Fig.”
Fakhiri, J., Landegger, L. D., & Grimm, D. (2020) · Hearing Research · doi:10.1016/j.heares.2020.108092 · Cited by 15
Large, E. E., & Chapman, M. S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1116896 · Cited by 18
“PKD1-5 were identified as important for AAV transduction (Pillay et al., 2016; Pillay and Carette, 2017).”
BackgroundMethodResultInfluentialSelf-citationChoi, S. J., Yi, J. S., Lim, J., Tedder, T. F., Koeberl, D. D., Jeck, W. R., Desai, A. K., Rosenberg, A. S., Sun, B., & Kishnani, P. S. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3509 · Cited by 14
Role of Tetra Amino Acid Motif Properties on the Function of Protease-Activatable Viral Vectors
Robinson, T. M., Judd, J., Ho, M. L., & Suh, J. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00439 · Cited by 14
AAV13 Enables Precise Targeting of Local Neural Populations
Han, Z., Luo, N., Wu, Y., Kou, J., Ma, W., Yang, X., Cai, Y., Ma, L., Han, L., Wang, X., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112806 · Cited by 16
“, HSPG), followed by co-receptor-mediated endocytotic entry; the cellular protein AAVR was implicated as an essential receptor for entry across a panel of AAV serotypes into representative cell types and, in vivo, in mice [32,33].”
BackgroundComparative structural, biophysical, and receptor binding study of true type and wild type AAV2
Bennett, A. D., Hull, J. A., Jolinon, N., Tordo, J., Moss, K., Binns, E., Mietzsch, M., Hagemann, C., Linden, R. M., Serio, A., et al. (2021) · Journal of Structural Biology · doi:10.1016/j.jsb.2021.107795 · Cited by 14
Zhang, R., Liu, Y., Yu, F., Xu, G., Li, L., Li, B., & Lou, Z. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011953 · Cited by 14
Zhang, Y., Chen, Z., Wang, X., Yan, R., Bao, H., Chu, X., Guo, L., Wang, X., Li, Y., Mu, Y., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.07.023 · Cited by 13
Viruses Like Sugars: How to Assess Glycan Involvement in Viral Attachment
Mathez, G., & Cagno, V. (2021) · Microorganisms · doi:10.3390/microorganisms9061238 · Cited by 14
“In previous works, summarized in Table 1, it has led to the recognition of essential genes involved in the synthesis of SA for EV-D68 [29], α-dystroglycan glycosylation for the Lassa mammarenavirus (LASV) [26], HS expression for the vaccinia and Rift Valley fever viruses [27,28], and even receptor identification for a…”
BackgroundSingle-Cell Transcriptome Atlas of Newcastle Disease Virus in Chickens Both In Vitro and In Vivo
Liu, W., Xu, Z., Qiu, Y., Qiu, X., Tan, L., Song, C., Sun, Y., Liao, Y., Liu, X., & Ding, C. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05121-22 · Cited by 19
Chen, Q., Njenga, R., Leuchs, B., Chiocca, S., Kleinschmidt, J. A., & Müller, M. (2020) · Journal of Virology · doi:10.1128/jvi.00871-20 · Cited by 14
“Recently, AAVR has been described as a proteinaceous receptor essential for several AAV serotypes (15), although it remains to be elucidated at which stage of AAV entry it plays a role.”
BackgroundFluorescence Microscopy in Adeno-Associated Virus Research
Golm, S. K., Hübner, W., & Müller, K. M. (2023) · Viruses · doi:10.3390/v15051174 · Cited by 13
“A further receptor found to be essential for most serotypes is the AAV receptor (AAVR), which is a type 1 transmembrane protein encoded by the KIAA0319L gene [23].”
BackgroundA humanized mouse model for adeno-associated viral gene therapy
Barzi, M., Chen, T., Gonzalez, T. J., Pankowicz, F. P., Oh, S., Streff, H. L., Rosales, A., Ma, Y., Collias, S., Woodfield, S. E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46017-0 · Cited by 15
“Recently, a universal AAV receptor (AAVR) has been identi fi ed 15 .”
BackgroundMethodChallenges in AAV-Based Retinal Gene Therapies and the Role of Magnetic Nanoparticle Platforms
Siontas, O., & Ahn, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237385 · Cited by 13
Wu, F., He, W., Xiao, Y., Wu, Q., Zhang, Q., Zhang, T., Xu, L., & Pang, X. (2025) · Advanced Science · doi:10.1002/advs.202408397 · Cited by 17
Pigeyre, L., Schatz, M., Ravallec, M., Gasmi, L., Nègre, N., Clouet, C., Sevéno, M., Koulali, K. E., Decourcelle, M., Guérardel, Y., et al. (2019) · Viruses · doi:10.3390/v11090870 · Cited by 15
“They highlight the importance of glycans in capsid recognition and binding specificity [6] [7] [8] .”
BackgroundKim, S., Lee, S., Lee, H., Cho, M., Schaffer, D. V., & Jang, J. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.015 · Cited by 12
“Alternatively, a receptor that interacts with all of the AAV serotypes tested to date, denoted as the AAV receptor (AAVR), was recently identified.(25)”
BackgroundInfluentialBauer, A., Puglisi, M., Nagl, D., Schick, J., Werner, T. A., Klingl, A., Andari, J. E., Hornung, V., Kessler, H., Götz, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202104979 · Cited by 21
Martino, R. A., Wang, Q., Xu, H. Y., Hu, G. B., Bell, P. L., Arroyo, E. J., Sims, J. J., & Wilson, J. M. (2023) · Journal of Virology · doi:10.1128/jvi.00174-23 · Cited by 13
“An interesting area of future research would be to apply these methods to the study of native capsid interactions with AAVR (57) or GPR108 (56) as well as engineered capsid interactions with integrins (29), major histocompatibility complex class I (MHC-I) (30), CA4 (31), or Ly6c1 (32) to determine whether the affinity…”
BackgroundWang, W., Fu, W., Pan, D., Cai, L., Ye, J., Liu, J., Liu, C., Que, Y., Xia, N., Zhu, H., et al. (2017) · Virologica Sinica · doi:10.1007/s12250-017-4048-x · Cited by 12
“Firstly, we found that both ORF7 and ORF53 co-localized well with the TGN46 protein (Figure 3A and 3B), which is widely used as a TGN marker in numerous studies (Barr et al., 2010; Donsante et al., 2011; Zhao et al., 2012; Charles et al., 2014; Nonnenmacher et al., 2015; Pillay et al., 2016).”
Rego, M. A., Hanley, L. M., Ersing, I., Guerin, K. I., Tasissa, M., Haery, L., Mueller, I., Sanders, E., & Fan, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/488585 · Cited by 12
Minno, G. D., Miesbach, W., Castaman, G., & Peyvandi, F. (2024) · Haematologica · doi:10.3324/haematol.2023.284622 · Cited by 21
Mammalian haploid stem cells: establishment, engineering and applications
He, W., Chen, J., & Gao, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03069-6 · Cited by 11
Synthesis and Concomitant Assembly of Adeno-Associated Virus-like Particles in Escherichia coli
Le, D. T., Radukic, M. T., Teschner, K. E., Becker, L., & Müller, K. M. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00451 · Cited by 12
Large, E. E., Silveria, M., Weerakoon, O., White, T., & Chapman, M. S. (2022) · Journal of Virology · doi:10.1128/jvi.01484-22 · Cited by 13
“The C-terminus has a predicted transmembrane protein domain and 56 cytosolic domain responsible for trafficking AAV through the trans-Golgi network (TGN) 57 (6).”
BackgroundMethodSelf-citationZheng, Z., Ye, J., Leng, M., Gan, C., Tang, N., Li, W., Valencia, C. A., Dong, B., & Chow, H. Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1188290 · Cited by 11
“Overexpression of AAVR was shown to increase the rAAV2 infection efficiency up to approximately 3-fold (Pillay et al., 2016).”
BackgroundResultInfluentialChen, Y., Wang, J., Liu, J., Lin, J., Lin, Y., Nie, J., Qi, Y., Deng, C., Qi, X., Li, Y., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01091-0 · Cited by 12
“The core event during the invasion of a cell by an AAV is receptor-mediated endocytosis [29, 30].”
The later stages of viral infection: An undiscovered country of host dependency factors
King, C. R., & Mehle, A. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008777 · Cited by 12
Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex
de Alencastro, G., Puzzo, F., Pavel-Dinu, M., Zhang, F., Pillay, S., Majzoub, K., Tiffany, M. R., Jang, H., Sheikali, A., Cromer, M. K., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.020 · Cited by 13
Self-citationEmerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies
von Jonquières, G., Rae, C. D., & Housley, G. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661857 · Cited by 12
“A notable advantage of gene editing is the preservation of normal copy numbers and gene regulation (Pinyon et al., 2019; Wagenblast et al., 2019).”
BackgroundNeuraminidase‐mediated desialylation augments AAV9‐mediated gene expression in skeletal muscle
Zhu, H., Wang, T., Lye, R. J., French, B. A., & Annex, B. H. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3049 · Cited by 14
“in an unbiased genetic screen has yielded new insight.(31) The AAVR was shown to play an essential role in infection by multiple AAV serotypes (including AAV1, AAV2, AAV3b, AAV5, AAV6, AAV8 and AAV9) with respect to mediating rapid endocytosis from the plasma membrane and trafficking to the trans‐Golgi network.”
BackgroundPowell, S., & McCown, T. J. (2024) · Journal of Virology · doi:10.1128/jvi.01681-24 · Cited by 10
“Two host factors were identified that aid in AAV cellular transduction, AAVR (14) and GPR108 (15).”
Minin, G. D., Postlmayr, A., & Wutz, A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005950 · Cited by 10
Kemmerer, M., & Bonning, B. C. (2018) · Insect Science · doi:10.1111/1744-7917.12600 · Cited by 13
Erratum: Corrigendum: An essential receptor for adeno-associated virus infection
Pillay, S., Meyer, N., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., et al. (2016) · Nature · doi:10.1038/nature19835 · Cited by 10
Self-citationTissue blood volumes and weights in adult beagle dogs.
Cuddihy, R. G., Hall, R. P., HOBBS, C. H., Boecker, B. B., & Muggenburg, B. A. (1972) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 10
Fu, Y., Choudhary, D., Liu, N., Moon, Y., Abdubek, P., Sweezy, L., Rosconi, M. P., Palackal, N. T., & Pyles, E. A. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115562 · Cited by 13
Innovative gene delivery systems for retinal disease therapy
Wu, H., Dong, L., Jin, S., Zhao, Y.-W., & Zhu, L. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00797 · Cited by 12
“SA serves as the primary receptor for AAV1, AAV4, AAV5, and AAV6, and Gal is the main receptor for AAV9 (Srivastava, 2016).”
InfluentialCRISPR-Cas: a game-changer in vaccine development and the fight against viral infections
Yang, F., Aliyari, S. R., Zhu, Z., Zheng, H., Cheng, G., & Zhang, S. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.02.006 · Cited by 11
iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy
Berreur, E., Lazzaroni, G., Roth, C., Zihlmann, M., Stirn, M., Matheis, R., Xicluna, R., Breous-Nystrom, E., & Roth, A. B. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101467 · Cited by 10
“33 Heparan sulfate protegoglycans (HSPGs) also serve as key initial binding sites for some AAV serotypes, notably AAV2.”
Cui, M., Lü, Y., Tang, C., Zhang, R., Wang, J., Yang, S., Cheng, S., & Ding, W. (2019) · Molecules · doi:10.3390/molecules24213973 · Cited by 11
“PKD2 is the major interface interacting with the AAV2 capsid, but not AAV4 or possibly other serotypes [20,21].”
BackgroundMethodSystem-Based Approaches to Delineate the Antiviral Innate Immune Landscape
Krey, K., Babnis, A. W., & Pichlmair, A. (2020) · Viruses · doi:10.3390/v12101196 · Cited by 10
Zuniga, A., Smith, M. L., Caruso, M. A., & Ryabinin, A. E. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108795 · Cited by 9
Viral-mediated gene therapy in pediatric neurological disorders
Peng, J., Zou, W., Wang, X., Zhang, Z., Huo, R., & Yang, L. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-022-00669-4 · Cited by 11
“Host-derived anti-KIAA0319 L antibodies can block its binding to AAV, a mechanism first identified in AAV2 and later confirmed in more serotypes [68].”
Cryo-EM structure of adeno-associated virus 4 at 2.2 Å resolution
Zane, G. M., Silveria, M., Meyer, N., White, T., Duan, R., Zou, X., & Chapman, M. S. (2023) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798322012190 · Cited by 10
Self-citationBall, J., Frank, M. G., Green-Fulgham, S. M., & Watkins, L. (2024) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2024.03.005 · Cited by 9
Meyer, N., Davulcu, O., Xie, Q., Silveria, M., Zane, G. M., Large, E. E., & Chapman, M. S. (2020) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3513 · Cited by 10
Self-citationMembrane fusion FerA domains enhance adeno-associated virus vector transduction
Zhang, X., Anthony, B., Chai, Z., Dobbins, A. L., Sutton, R. B., & Li, C. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119906 · Cited by 10
The milestone of genetic screening: Mammalian haploid cells
Sun, S., Zhao, Y., & Shuai, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.006 · Cited by 10
Kono, K., Sawada, R., Kuroda, T., Yasuda, S., Matsuyama, S., Matsuyama, A., Mizuguchi, H., & Sato, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-36848-5 · Cited by 9
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
Mnyandu, N., Limani, S. W., Arbuthnot, P. B., & Maepa, M. B. (2021) · Virology Journal · doi:10.1186/s12985-021-01715-9 · Cited by 9
Zhang, X., Hao, S., Feng, Z., Ning, K., Küz, Ç. A., McFarlin, S., Richart, D., Cheng, F., Zhang-Chen, A., McFarlane, R., et al. (2024) · mBio · doi:10.1128/mbio.03268-24 · Cited by 9
The amazing AAV capsids: Into the structure-verse
Hsi, J., Mietzsch, M., & McKENNA, R. V. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101629 · Cited by 12
Loeb, E. J., Fergione, S., Yudistyra, V., Fanous, M. M., Benkert, A. R., Fisher, D. G., Hull, J. A., ElMallah, M. K., & Asokan, A. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102475 · Cited by 14
“20,30 Further investigation of the cellular uptake mechanisms of AAV.div3A is ongoing.”
Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
Huang, K., Tian, J., Zhao, W., Zhang, S., Xiang, L., Yang, M., Ls, L., Huang, Y., Zhang, N., Sun, L., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70115 · Cited by 10
Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene Therapy
Pipe, S. W., Arruda, V. R., Lange, C., Kitchen, S., Eichler, H., & Wadsworth, S. C. (2022) · Current Gene Therapy · doi:10.2174/1566523222666220914105729 · Cited by 9
“AAV tissue tropism is partially dictated by an interaction between the capsid and receptors expressed on target cells, including proteoglycans [50, 51], with nonreceptor-mediated cell entry also possible [52].”
BackgroundBieńkowska, A., Ducher, M., Orzechowska, M., Słyk, Ż., Ciepiela, O., Jaworowski, J., & Małecki, M. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8112 · Cited by 10
“In 2016, a study published in Nature was the key to determine the concept of the cellular transmission of rAAV (6).”
BackgroundAAV Entry: Filling in the Blanks
Büning, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.015 · Cited by 9
“Nevertheless, when re-analyzing data from the initial AAVR screen, GPR108 was already present among the hits.(4)”
BackgroundMethodSherpa, C., & Grice, S. F. J. L. (2020) · Current HIV Research · doi:10.2174/1570162x18666200210121339 · Cited by 8
Preparation and Administration of Adeno-associated Virus Vectors for Corneal Gene Delivery
Song, L., Bower, J. J., & Hirsch, M. L. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0599-8_7 · Cited by 8
Metadata
- Authors
- Pillay, S., Meyer, N. L., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., & Carette, J. E.
- Affiliations
- Stanford Medicine (US)
- Oregon Health & Science University (US)
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Chapman, M. S.
- Carette, J. E.
- ORCID
- Venue
- Nature
- Published
- 2016-01-27
- Volume
- 530
- Issue
- 7588
- Pages
- 108-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4962915
- OpenAlex
- W2266837556
- Cited by
- 532
- References
- 33
- Citations by year
- 2026: 58 · 2025: 51 · 2024: 63 · 2023: 60 · 2022: 36 · 2021: 47 · 2020: 57 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 28
- FWCI
- 43.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-09-28)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (5u19ai109662-05)
- National Institute of General Medical Sciences (R01GM066875)
- National Institute of Allergy and Infectious Diseases (DP2AI104557, U19-AI109662)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- adeno-associated virus, AAV receptor, AAV2, viral entry, host factors, endocytosis, AAV serotypes, gene therapy vectors, viral gene delivery
- MeSH terms
- Dependovirus, Animals, Antibodies, Cell Line, Endocytosis, Female, Humans, Male, Parvoviridae Infections, Receptors, Cell Surface, Receptors, Virus, Genetic Therapy, Gene Deletion, trans-Golgi Network, Mice, Virus Internalization, Viral Tropism, Host Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.